Icos Stocks List

Recent Signals

Date Stock Signal Type
2021-04-20 ALIM Fell Below 50 DMA Bearish
2021-04-20 ALIM Stochastic Reached Oversold Weakness
2021-04-20 ALPN 20 DMA Support Bullish
2021-04-20 ALPN Bollinger Band Squeeze Range Contraction
2021-04-20 ALPN Doji - Bullish? Reversal
2021-04-20 ALPN Hammer Candlestick Bullish
2021-04-20 ALPN 200 DMA Support Bullish
2021-04-20 AMRN New Downtrend Bearish
2021-04-20 AMRN Calm After Storm Range Contraction
2021-04-20 AMRN NR7 Range Contraction
2021-04-20 ANGO MACD Bearish Signal Line Cross Bearish
2021-04-20 CHS Expansion Pivot Sell Setup Bearish Swing Setup
2021-04-20 CHS Bollinger Band Squeeze Range Contraction
2021-04-20 CHS Lower Bollinger Band Walk Weakness
2021-04-20 FTS Stochastic Reached Overbought Strength
2021-04-20 FTS New 52 Week High Strength
2021-04-20 FTS New 52 Week Closing High Bullish
2021-04-20 INVA Crossed Above 20 DMA Bullish
2021-04-20 INVA Bollinger Band Squeeze Range Contraction
2021-04-20 INVA 200 DMA Support Bullish
2021-04-20 INVA 50 DMA Support Bullish
2021-04-20 LMAT Cup with Handle Other
2021-04-20 OPTN Bollinger Band Squeeze Range Contraction
2021-04-20 OZON 50 DMA Support Bullish
2021-04-20 TLC Fell Below 20 DMA Bearish
2021-04-20 TLC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup

Icos Corporation (trademark ICOS) was an American biotechnology company and the largest biotechnology company in the U.S. state of Washington, before it was sold to Eli Lilly and Company in 2007. It was founded in 1989 by David Blech, Isaac Blech, Robert Nowinski, and George Rathmann, a pioneer in the industry and Chief Executive Officer (CEO) and co-founder of Amgen, Icos focused on the development of drugs to treat inflammatory disorders. During its 17-year history, the company conducted clinical trials of twelve drugs, three of which reached the last phase of clinical trials. Icos also manufactured antibodies for other biotechnology companies.
Icos is famous for tadalafil (Cialis), a drug used to treat erectile dysfunction. This drug was discovered by GlaxoSmithKline, developed by Icos, and manufactured and marketed in partnership with Eli Lilly. Boosted by a unique advertising campaign led by the Grey Worldwide Agency, sales from Cialis allowed Icos to become profitable in 2006. Cialis was the only drug developed by the company to be approved. LeukArrest, a drug to treat shock, and Pafase, developed for sepsis, were both tested in phase III clinical trials, but testing was discontinued after unpromising results during the trials. Eli Lilly acquired Icos in January 2007, and most of Icos's workers were laid off soon after. CMC Biologics, a Danish contract manufacturer, bought the remnants of Icos and retained the remaining employees.

More about Icos
Browse All Tags